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Abstract 
OBJECTIVES: To analyze the role of smoking, drinking and their synergistic effect in the occurrence of 
potentially malignant oral disorders (PMOD). 
SUBJECTS AND METHODS: We examined three groups: 50 lung cancer patients, 50 patients with 
liver cirrhosis and 50 patients with clear medical history. Scores were developed for drinking, smoking, 
drinking and smoking and PMOD.  
RESULTS: All four scores were the lowest in the control group. The lung cancer group showed the 
highest Smoking, Alcohol & Smoking and Lesions score, while the liver cirrhosis group had the Alcohol 
score the highest. Compared to the control group, lung cancer group is more likely to develop a PMOD 
than the liver cirrhosis group (OR=12.31/ OR=6.71).  Statistical significance between the groups was 
found in the Lesions score (χ
2
=15.34; p=0.001). 
CONCLUSIONS: The lung cancer and liver cirrhosis patients represent a high risk group for PMOD. 
Lung cancer and liver cirrhosis patients have never, to our knowledge, been categorized as high risk 
patients for PMOD. After diagnosed, lung cancer and liver cirrhosis patients should have a routine oral 
cavity examination, as they present a high risk group for PMOD and oral cancer.      
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Introduction  
According to the WHO (World Health Organization), oral cancer (OC) is the eight most common 
cancer in the world (Petersen, 2009). More than 300,000 new cases worldwide are diagnosed with oral 
squamous cell carcinoma annually (Rivera, 2007). Approximately 40,000 new cases are recorded in the 
European Union annually (Tsantoulis et al, 2007).  OC predominantly appears in middle aged people and 
older. Overall incidence and mortality attributed to oral cancer is increasing, with age-standardized 
incidence and mortality of 6.6/100,000 and 3.1/100,000 for males, and 2.9/100,000 and 1.4/100,000 for 
women (Mehrotta and Yadav, 2006). Many authors set an incidence ratio between men and women 2:1, 
but since more and more women are adopting unhealthy habits, the difference in future will surely 
decrease. At the beginning of the 20
th
 century, the incidence ratio was 9:1 (Shah et al, 2003). According 
to WHO, in the developed countries, OC in the male population is the sixth most common cancer after 
lung, prostrate, colorectal, stomach and bladder cancer, while in female population, it takes the 10
th
 place 
after breast, colorectal, lung, stomach, uterus, cervix, ovary, bladder and liver (Mehrotta and Yadav, 
2006).  
Alcohol is a carcinogenic via several mechanisms with a local and systemic effect on the oral 
mucosa. Tobacco generates carcinogens such as tobacco-specific nistrosamines and free radicals with a 
specific effect on the antioxidant enzymes. Smoking increases the acetalaldehyde burden following the 
alcohol consumption and alcohol consumption enhances the activation of pro-carcinogens present in 
tobacco (Scully and Petii, 2010).  
In the 2005 WHO classification of oral lesions with a predisposition to malignant transformation, 
the term potentially malignant was preferred above premalignant or precancerous. It was recommended to 
abandon the terms “potentially malignant lesions” and “potentially malignant conditions” and to use the 
term “potentially malignant disorders” instead (PMOD). This was referred to erythroplakia, leukoplakia, 
lichen planus, oral submucous fibrosis and some miscellaneous potentially malignant disorders, like 
actinic cheilitis, inherited cancer syndromes and immunodeficiency (van der Waal, 2009).  
In the last decade, there has been an increased interest in oral cancer screening (Logan et al, 
2013). Unfortunately, till this day, there is no definitive evidence that un-targeted screenings are cost-
effective. OC screenings in low-incidence areas could be more cost-effective if they targeted high-risk 
groups for oral cancer, heavy smokers and alcohol consumers.  
The aim of the study is to determine the type, frequency and localization of the PMOD in patients 
with lung cancer and liver cirrhosis. These are chosen under consideration that the majority of the 
respondents have the risk habits for oral cancer development, smoking and alcohol consumption. We aim 
to correlate smoking, alcohol consumption, synergistic effect of alcohol and smoking with the appearance 
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of PMOD. Furthermore, we aim to emphasize that head and neck cancer screening clinics should target 
patients at high risk and attempt to ensure appropriate follow-up thereafter. 
We haven’t found any studies on PMOD in lung cancer and liver cirrhosis patients and never 
have lung cancer and liver cirrhosis patients been targeted as a risk group for PMOD or OC.  
 
Materials and methods 
One hundred and fifty respondents were examined in the General Hospital Pula, Croatia. The first 
group was made out of fifty respondents diagnosed with lung cancer, the second of fifty respondents that 
had liver cirrhosis and the third, the control group, was consisted of trauma patients with a clear medical 
history, admitted to the Department of Traumatology.  
The study was reviewed and approved by the Ethic Committee of the School of Dental Medicine, 
University of Zagreb.  
The respondents were examined in the departmental clinic by two doctors of dental medicine and 
two oral surgery specialists independently. Patients with suspicious findings, decubiti and PMOD were 
encouraged to follow-up and were given follow-up recommendations.   
The respondents were given a questionnaire divided in two parts: 
1. General information (age, gender, respondent's consent to participate in the research)  
2.  Anamnesis data (information about smoking habits, and alcohol consumption) 
Four score variables were created:  
1. Score “Smoking” = (duration of smoking (years) x number of cigarettes per day) / time since 
quitting smoking (years). 
2. Score “Alcohol” = (duration of alcohol consumption (years) x alcohol units per day) / time since 
quitting drinking (years). Alcohol units were used to unify the criteria among alcoholic 
beverages. One alcohol unit contains 10g of pure alcohol. One alcohol unit is found in 125mL of 
wine, 300mL of beer and 30mL of strong liquor.  
3. Score “Alcohol & Smoking” = (“Alcohol” + “Smoking”) / 2  
Respondent had to drink and smoke in order to have a value different than 0.    
4. Score “Lesions” = lesions in the oral cavity were evaluated according to their malignancy 
potential and localisation. Malignancy potential was graded, started from the smallest: lichen, 
leukoplakia, erythroplakia.  
The lesion’s distinctive feature of the site appearance was described either as: 
• Characteristic – inside the “horseshoe” 
• Uncharacteristic – outside the “horseshoe” 
Lesions were scored from one to five:   
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• no lesion    0 
• lichen    1 
• uncharacteristic leukoplakia  2 
• characteristic leukoplakia  3 
• uncharacteristic erythroplakia  4 
• characteristic erythroplakia   5 
 
In case of multiple lesions, the values were summoned.    
The data was organized into files (Microsoft Excel, Microsoft Inc., USA) and processed by 
JMP7 module from the software package SAS (SAS Institute Inc., Cary, NC, USA). Statistically 
significant results were found only if p<0.05. The value of χ
2
 test was shown only when p<0.05. χ
2
 test, 
where applicable, was used to compare qualitative data. Among other measures of association, relative 
risk and odds ratio were used. Quantitative data distribution was tested by Kolmogorov-Smirnov test. To 
compare more than two independent groups, the Kruskal-Wallis χ
2
 test was used. Testing between groups 
was done by Mann-Whitney U test. 
 
Results 
The average age of the respondents in all groups is 61.51. The age distribution is shown in table 
1. We examined 120 (80%) men and 30 (20%) women. Among the respondents there were 111 (74%) 
smokers and 39 nonsmokers (26%). Among 111 smokers 52 (47%) stopped smoking after the disease 
diagnosis and 59 (53%) are still smoking.  
Among 133 of the respondents who drink alcohol, 84 (63%) of them consume only low alcoholic 
beverages (under 15% of alcohol) and 49 (37%) of them also drink stronger drinks. After their diagnosis, 
thirty of them (22.5%) stopped drinking, while the other (77.5%) are still consuming alcohol.   
Duration of smoking in respondents with lung cancer is the longest (34.19 years), but there is no 
statistical significance in smoking duration between the three groups (p=0,107). On average, the largest 
amount of cigarettes per day is consumed by the respondents with lung cancer (27.54) and no statistical 
significance was found between the groups. The average score “Smoking” in the lung cancer group is 
849.60, while in the control group the score is 412.35. The liver cirrhosis group has the average score 
565.10.  
The group with liver cirrhosis drinks, on average, 12 alcohol units per day and there is a statistical 
significance between the three groups (χ
2
=30.68; p=0.001). The average score “Alcohol” is 391.63 in the 
liver cirrhosis group, 292.80 in the lung cancer group and 173.14 in the control group.  The maximal 
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value of the one individual in the control was 1197.00, which significantly affects the mean.  The median 
for the score was 320.00 for the liver cirrhosis group, 287.50 for the lung cancer and 90.00 for the control 
group.  
The score “Alcohol & Smoking” was highest in the lung cancer group (530.48), followed by the 
liver cirrhosis (399.95) and the control group (231.73). Lung cancer group has 41, liver cirrhosis group 35 
and the control group 21 tobacco and alcohol consumers. 
The score “Lesions” is highest in the lung cancer group and amounts to 0.92, lowest in the control 
group (0.10) and in the liver cirrhosis group it amounts to 0.64. Statistical significance was found between 
the groups (χ
2
=15.34; p=0.001). 
The distribution of PMOD is shown in table 2. Due to their frequency, we found no statistical 
significance between the score “Lesions” and all other scores between the groups. The risk of developing 
a potentially malignant disorder between the risk groups and the control group is shown in table 3.  
All of the respondents who were diagnosed with a lesion had either a smoking or a drinking habit 
or both. Table 4 describes the disorders with regards to the respondents habits. Each lichen lesion found 
was located outside the „horseshoe“. Leukoplakia was found in 16 respondents (10.6%), out of which 12 
(75%) was located outside the horseshoe. Erythroplakia was found in seven respondents, out of which 
five (71.4%) lesion were located inside the horseshoe. 
The score comparison between groups is shown in table 5. 
 
Discussion 
The developed scores integrated several variables and allowed us to represent all the variables as 
quantitative data.  Our limitations are our small sample size and an unequal gender distribution. 
Unfortunately, we cannot completely rule out some unevaluated confounders, like human papilloma virus 
infection. A biopsy of the lesions wasn’t taken, however bias of the estimator has been minimized by the 
number of examiners. We selected healthy individuals for our control group from the Department of 
Traumatology. The selection bias here is possible, due to our selection of patients with clear medical 
history, under intention that these represent the non-targeted screening population. By targeting and 
defining the risk groups, we avoided the systemic bias. 
According to studies on the topic, smoking and alcohol consumption is more prominent in men, 
however as mentioned before, the ratio between genders is dropping (Petti S, 2009).   
Studies show that over 98% of oral cancer patients are over forty (Bonifazi et al, 2011). We only 
found one age-targeted prevention campaign for population over 60 in Sao Paulo (Martins et al, 2012). 
The campaign was beneficial to the oral health of elderly with a significant reduction of oral cancer cases. 
The average age of our respondents is 61.51. Even though age mean is similar between groups, the 
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control group was not age-matched to the risk groups. The oldest respondent in the control group is 93 
years old, eleven years older than the oldest respondent in the risk groups. This could present a study 
limitation. However, we believe that the presented age difference is not a confounding factor.  
As expected, the score “Smoking” is 35% higher in the lung cancer group than in the liver 
cirrhosis group and 50% higher than in the control group. The liver cirrhosis had the highest “Alcohol” 
score. By considering the time from quitting smoking and drinking, we avoided the upward bias in the 
smoking and drinking frequency. The synergistic effect of alcohol and smoking was already noticed in 
1972 (Rothman and Keller, 1972). We didn’t expect to find a 25% higher “Alcohol & smoking” score in 
the lung cancer group compared to the liver cirrhosis group. The reason for this is the higher “Smoking” 
score ratio than the “Alcohol” score ratio between the two high risk groups.  
Score “Lesions” was most sensitive to the malignancy potential developed in respect to previous 
studies on the subject and its localization (van der Waal, 2009).  As predicted, PMOD were more frequent 
in the high risk groups (p=0,001). In both high risk groups the score “Lesions” is ten times higher than in 
the control group. Even though we found no statistical significance in score “Lesions” between the lung 
cancer and liver cirrhosis group, score is 1.44 times higher in the lung cancer group. We couldn’t calculate 
the χ
2
, RR or OR for leukoplakia, erythroplakia and loral lichen individually because of the small sample 
size. Nevertheless, as shown in table 3, statistical significance was found between risk groups and the 
control group in PMOD distribution, when all lesions observed together.  
The most common localisations (75-85%) of oral cancer are the sublingual and paralingual 
region. The anatomical structures most commonly affected (soft palate, front pharyngeal arch, retromolar 
region, ventral and lateral parts of the tongue) are less keratinized and therefore more prone to dysplasia 
(Shenoi et al, 2012).  In the western countries, 80% of all carcinomas develop in 20% of the oral cavity 
surface.  This area forms a horseshoe shape and covers the mouth floor, ventral and lateral surface of the 
tongue, retromolar trigonum and the palatal arches. A horseshoe shape area represents a “reservoir” in 
which the carcinogens dissolved in saliva gather. Macan et al (2007)  showed that among alcoholics, these 
parts are exposed to carcinogens for 24 hours after consumption, since alcohol is retained in the oral 
cavity for a while and then afterwards exuded through saliva. The interesting fact is that we found 75% of 
leukoplakia lesions outside the horseshoe.  However, 75% of all erythroplakia lesions were located inside 
the horseshoe, while we found none in the control group. Unfortunately, size of the lesions, as a predictive 
factor, wasn’t recorded. Brouns et al. (2014) showed that the size of the leukoplakia lesions over 4cm 
could be the only predictive factor of malignant transformation.  
Sarode et al (2011) suggested a new classification where leukoplakia is a habit related 
morphologically altered tissue and oral lichen a morphologically altered tissue where chronic 
inflammation is responsible for malignant transformation. Erythroplakia hasn’t been described as a 
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potentially malignant disorder in this classification, probably because they are considering it a carcinoma 
in situ.  
Since the scientists haven’t agreed on the malignancy potential of lichen, it is conditional to call it 
a potentially malignant disorder. This is the reason why lichen was given less points in the score 
“lesions”. Brzak et al (2012) did a retrospective study on 12508 patients with lichen and leukoplakia and 
during the period of ten years did not find any malignant transformation in patients with lichen. On the 
other hand, Tovaru et al (2013), in an another retrospective study, out of 633 patients with lichen, after 
0.5-20 years after its diagnosis, found six cases of oral squamous cell carcinoma (OSCC) at the site of 
previously confirmed lichen. The percentage (0.95%) isn’t big, but has to be taken into account. 
Manojlovic et al (2007) described five OSCC lesions which aroused from the preexisting oral lichen 
planus. All of the respondents with oral lichen were recommended to an oral medicine specialist.  
 Clinical examination by a specialist of oral and maxillofacial surgery was recommended to all the 
respondents diagnosed with erythroplakia or leukoplakia. This referred to 23 respondents: twelve in the 
lung cancer group, nine from the liver cirrhosis group and two from the control group. Eighteen out of 23 
drank and smoked, and the rest just smoked. Five of them drank strong liquor, which could support the 
observation that the amount of alcohol is more influential than the type of alcohol, highlighting the local 
effect of alcohol. The localisation of the higher concentrations of direct alcohol and alcohol excreted in 
saliva are in correlation with typical localisations of oral cavity cancer  (Macan, 1999; Macan et al,  
2007). Bagnardi et al (2013) showed that even light drinking (up to 1 drink/day) increases the risk of 
oropharyngeal cancer (RR =1.30; 95% CI 1.09-1.56). 
In the lung cancer group we found three erythroplakia lesions located on the soft palate, while in 
the liver cirrhosis group we found none on that localisation. This is consistent with the studies by which 
smoking more frequently causes PMOD and OC located on the palate, while alcohol is considered to be 
more responsible for lesions located on the floor of the oral cavity (Macan, 1999). This could depict the 
local effect of tobacco and alcohol.   
 Other PMOD than the ones mentioned, weren’t detected in this study.  
Despite the efforts in early detection of oral cancer, surgery, radiation and chemotherapy, a five-
year survival rate is 50% or less (Markopoulos, 2012). Most of the patients seek for medical opinion only 
when they experience lasting pain, dysphagia or swelling, which are often signs of an advanced malignant 
disease. Needless to state, treatment is more effective in the initial stages and the morbidity is minimal. 
Early diagnosis provides a higher survival rate, less mutilating surgery, faster recovery and less expense.  
Improved patient outcome is the aim of screening and its benefit, while on the other hand, testing 
and investigating a healthy population, highly fluctuating geographic incidence of oral cancer, resources 
required, false positive referrals and poor cost-benefit ratio do not state its precedence. Neither the US 
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Preventive Services Task Force, The American Academy of Family Physicians nor the Canadian Task 
Force on Preventive Health Care recommend routine screening for head and neck cancer (Moyer 2013; 
Shuman et al, 2013). They all state the lack of evidence that screening for oral cancer led to improved 
health outcomes.  
Due to self-selection among patients presenting for screening, traditional risk factors may not be 
associated with the likelihood of detecting the oral cancer. Prior publications suggest that screening 
clinics should target patients at high risk (Linkov et al, 2007; Sankaranarayanan et al, 2013).  
In conclusion, lung cancer and liver cirrhosis patients present a high risk group for PMOD and 
should, after diagnosed, attend a routine oral examination, as they present a high risk group for PMOD 
and oral cancer. The four scores developed gave a clear and broad picture of the respondent’s habits. All 
four scores developed were lowest in the control group. The liver cirrhosis group had the score “Alcohol” 
the highest, while the lung cancer group had the scores “Smoking”, “Alcohol & smoking” and “Lesions” 
the highest. Lung cancer patients had almost twice the OR for developing a PMOD than the liver cirrhosis 
patients.  
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Table 1. Respondents age, alcohol and smoking information 
Feature 
Liver cirrhosis 
group 
Lung cancer 
group 
Control 
group 
Age 
Mean; Standard 
deviation 58.58; 11.44 64.84; 8.11 61.12; 17.10 
 
Minimal; Maximal 
value 38; 82 43; 77 38; 93 
Duration of smoking 
Mean; Standard 
deviation 31.80; 13.38 34.19; 14.21 27.06; 14.71 
No. cigarettes per day 
Mean; Standard 
deviation 26.57; 13.21 27.54; 10.83 23.16; 16.47 
No. alcohol units per 
day 
Mean; Standard 
deviation 12.00; 6.06 9.20; 5.03 5.71; 6.17 
Duration of drinking 
Mean; Standard 
deviation 32.80; 10.10 37.50; 10.14 37.05; 14.03  
 
 
 
 
Table 2. Potentially malignant oral disorders 
Lesion Liver cirrhosis group Lung cancer group Control group 
Lichen 6 10 1 
Leukoplakia 6 8 2 
Erythroplakia 3 4 0 
Total 15 22 3  
 
Table 3. Potentially malignant disorder risk between the risk groups and the control group 
Feature Liver cirrhosis - Control group Lung cancer – Control group 
RR 5.00 7.33 
OR 6.71 12.31 
CI (95%) 1.80 – 25.00 3.38 – 44.89 
z; p 2.839; 0.005 3.803; 0.001  
 
Table 4. Potentially malignant oral disorders in relation to smoking and alcohol consumption 
Habit Leukoplakia Erythroplakia Lichen All 
Smoking N (%) 13 (81.3) 7 (100.0) 15 (88.2) 35 (87.5) 
Alcohol N (%) 15 (93.8) 6 (85.7) 15 (88.2) 36 (90.0) 
Smoking and alcohol N (%) 12 (75.0) 6 (85.7) 13 (76.5) 31 (77.5) 
Don't drink & smoke N (%) 1 (6.3) 0 (0.0) 2 (11.8) 3 (7.5) 
All N (%) 16 (100.0) 7 (100.0) 17 (100.0) 40 (100.0)  
 
 
Table 5. Score comparison between two groups (Mann Whitney U test) 
 
Lung cancer and control group 
 Smoking Alcohol Smoking and Alcohol Lesions 
U 668.00 764.50 680.50 772.00 
p 0.003 0.003 <0.001 0.001 
Liver cirrhosis and control group 
U 1030.00 469.00 884.5 947.50 
p 0.363 0.003 0.017 0.038 
Lung cancer and liver cirrhosis group 
U 879.00 983.00 989.00 1079.50 
p 0.030 0.195 0.099 0.242 
 
 
